Sunshine Biopharma The Board of Directors authorizes a reverse split of up to 1:20
2026-09-17 04:12:44
According to CoinMeta, as reported by Reuters, the board of directors of Sunshine Biopharma has authorized a reverse split of common shares at a ratio of up to 1:20.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.